Wells Fargo lowered the firm’s price target on Bruker (BRKR) to $75 from $78 and keeps an Overweight rating on the shares. The silver lining in the second half of the year guide reset is that 2025 consensus numbers should rebase lower, which removes an overhang for investors.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR: